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ABSTRACT 
An organic molecule may crystalize in numerous distinct lattices and the slow and 
unpredictable transitions between multiple crystal forms is a significant concern in its 
pharmaceutical application. Recent results indicate that the transformation of olanzapine (OZPN) 
from anhydrous to hydrate crystals is mediated by mesoscopic solute-rich clusters. Here we 
demonstrate the existence of such clusters in undersaturated OZPN solutions in purely aqueous 
and mixed EtOH/aqueous solvents. The clusters occupy about 10-8 ± 10-7 of the solution volume 
and capture ca. 10-7 ± 10-5 of the dissolved OZPN. The average cluster radius is steady in time at 
about 35 nm and independent of the OZPN concentration and the solvent composition, whereas 
the OZPN fraction captured in the clusters is dictated by the solution thermodynamics. Both 
behaviors are in dire conflict with classical theories of phase transformation and recent 
aggregation models. They are, however, consistent with the predictions of a model that assumes 
the formation of OZPN dimers and their decay upon exiting the clusters. We propose that a 
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transient dimer, which may be akin to the centrosymmetric dimer present in all of the 60 known 
OZPN crystal structures, may underlie cluster formation. The finding of cluster formation in 
organic systems and the proposed cluster mechanism provide guidance towards enhanced control 
over nucleation, molecular transitions, and the solid forms in molecular systems.  
INTRODUCTION 
Numerous organic and inorganic molecules exhibit multiple solid forms spanning 
polymorphs, solvates, salts, co-crystals, and amorphous structures.1-4 Distinct crystal forms can 
have different crystallization free energy and, correspondingly, different thermodynamic stability 
impacting key biopharmaceutical attributes including solubility.5 Even though the selection of 
the crystal form determines the fundamental properties and, ultimately, the utility of the crystals, 
the available understanding of polymorphism is mostly empirical. The Ostwald step rule, 
suggesting that less stable phases appear earlier,6 provides limited guidance on the direction of 
transitions between crystal forms.7 The mechanism of transition between solid forms, which 
dictates the kinetics of the process, is among the major unsolved problems of modern 
chemistry.8-9   
Besides its fundamental significance, the potential variability of crystal forms has 
profound impact on the applications that rely of crystalline materials and their associated 
properties.10 A prime example is the manufacture of pharmaceutical products, where the majority 
of active pharmaceutical ingredients (APIs) are delivered as crystalline preparations and their 
bioavailability is governed by the crystal dissolution rate.11 As the crystal structure and 
composition dictate the solubility and bioavailability of the drug, polymorphic transformations 
are responsible for a wide range of formulation and manufacturing problems, such as unexpected 
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formation of another form during production and storage12 or changes in the physical and 
chemical properties in gastric or intestinal environments.13-14 
 
Scheme 1. The structure of olanzapine (OZPN). (a) The OZPN molecule. (b) The centrosymmetric dimer 
(OZPN)2 SC0 motif present in all crystal structures.15 S, yellow; N, blue; C, are grey; and H, white. (c) 
The crystal structure of the dihydrate ethanoate mixed solvate form OZPN:EtOH:H2O (2:1:2) in space 
group P21/c; Cambridge Structural Database REFCODE WEXQEW. OZPN dimers are drawn in in blue 
and green showing parallel dimers, EtOH molecules are drawn in purple, and water molecules, in red. 
 
Recent results with the antipsychotic drug olanzapine (OZPN),16 Scheme 1a, have 
demonstrated that the transition between a non-solvated polymorph, OZPN I, and a dihydrate 
(OZPN DD) follows a mechanism distinct from the one envisioned by classical nucleation 
theory. To date, more than 60 individual forms of OZPN have been identified15 that include three 
non-solvated polymorphs, I, II, III. In aqueous solution, OZPN I transform to OZPN dihydrates, 
DB and DE, which are metastable, and the stable DD. These six forms exhibit very low aqueous 
solubility; however, exact values of the solubility have not been reported owing to the rapid 
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phase transformation.14, 17 In all solvated and neat forms, OZPN molecules are arranged as 
dimers, in which parallel plates are bound by reciprocal contacts between the thiophene methyl 
group and the piperazine entity of the paired molecule, Scheme 1b. In the solvates, such as the 
dihydrate-ethanoate depicted in Scheme 1c, the solvent molecules stabilize the packing by 
occupying the voids between the dimers. The dimer packing arrangement has been disturbed in a 
number of OZPN salts as a consequence of the introduction of competing interactions between 
counterions.18-19 Crystal structure prediction calculations15 have suggested that non-solvated 
crystal structures based on non-dimeric OZPN are thermodynamically feasible; however, none 
have been obtained to date. 
The transformation of OZPN I to OZPN DD in unstirred solution is facilitated by an 
intermediate, liquid-like phase, that deposits as liquid clusters on {100} faces of OZPN I, Figure 
1a, and serves as nucleation medium for OZPN DD.20 When introduced into the solution bulk, 
the liquid clusters give rise to a metastable dihydrate polymorph, OZPN DB.20 Both observations 
starkly diverge from the generally envisioned polymorph transition pathways. The obvious one, 
by structural rearrangement in the solid state, is more likely for crystals of isometric molecules or 
particles, LQWHUDFWLQJZLWKD³VRIW´SRWHQWLDO LQZKLFKWKHDWWUDFWLYHPLQLPDDUHVKDOORZEURDG
and tolerant of molecular motion.21 For molecular crystals, in which the attractive forces are 
short-ranged, anisotropic, and strong, a more common option is by dissolution of the high free-
energy polymorph followed by crystallization of the stable form. 
5 
 
 
Figure 1. Dense OZPN-rich clusters (indicated with yellow arrows) on the surface of OZPN crystals 
imaged by atomic force microscopy. (a) Clusters on (100) face of OZPN I after incubation in water for 4 
h. As demonstrated in Warzecha, et al, 20, these clusters are a kinetic intermediate in the transformation 
from anhydrous OZPN I to the hydrated form OZPN DD. (b) Clusters on the surface of OZPN:EtOH:H2O 
after incubation for 1 h in saturated solution in EtOH/H2O 1/1 (v/v).  
 
Nucleation of OZPN DD and OZPN DB hosted by the dense liquid droplets contradicts 
the tenets of classical nucleation theory, according to which crystal embryos emerge in the 
solution by ordered assembly of solute molecules.22-25 On the other hand, it appears in accord 
with the two-step nucleation mechanism, according to which crystal nucleation is facilitated by 
dense liquid precursors.26-29 30-31 This mechanism has been observed with protein,26-27, 31-36 
colloid,37-39 inorganic,40-42 and organic28, 43-44 molecules. Macroscopic dense liquid, appearing 
DIWHU ³RLOLQJ RXW´ DQG stable with respect to the solution, has been observed with organic 
molecules.45 The OZPN dense liquid clusters, however, do not represent a stable phase: they 
form a relatively monodisperse population with dimeter of ca. 80 nanometers and their growth 
upon deposition on the crystal surface appears to be not by association of monomers from the 
solution, but by coalescence with other clusters, Figure 1.20 These clusters are also significantly 
larger than the disordered liquid clusters comprised of ca. 10 - 100 1,3,5-tris(4-
bromophenyl)benzene, or tribromide-Y molecules that host crystal nuclei;44 the size of the 
tribromide-Y clusters complies with the predictions of electrostatic aggregation models.46-47  
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Here we explore the enigma presented by the OZPN mesoscopic liquid clusters. We 
monitor the properties of the cluster population and its evolution and deduce the cluster 
formation mechanism. We draw an analogy to the protein-rich clusters of similar size, which 
assemble owing to the dynamics of formation and decay of transient dimers.48 We compare the 
cluster behaviors in solvents that contain varying amount of ethanol and demonstrate that the 
fraction of OZPN, captured in the clusters, is dictated by the thermodynamic parameters of the 
solutions. On the other hand, the cluster size is decoupled form the volume of the cluster 
population and is likely determined by the dynamics of cluster assembly.   
MATERIALS AND METHODS 
Solutions. Analytical grade solvents were purchased from Fisher Scientific and Sigma 
Aldrich. OZPN was purchased from Molekula Ltd., UK and used without further purification. 
Weighted amount of OZPN were dissolved in water and water-ethanol mixtures. Prior to 
characterization of aggregation, all solutions were filtered through a 0.22 Pm PTFE filter. 
Atomic Force Microscopy (AFM). AFM data were collected on a Dimension Fast Scan 
AFM (Bruker) equipped with Icon scanner, using PeakForce Tapping® mode at RT and 
ScanAsyst Air probe (Bruker) with nominal spring constant k =0.4 N/m and a nominal tip radius 
of 2 nm. OZPN I crystals were mounted with epoxy glue to a cover slip, placed in a 
crystallization dish, and submerged in a 5 cm3 volume of deionized water; no solution flow was 
applied. All AFM data was analyzed using NanoScope Analysis 1.5 software (Bruker). Height 
images were corrected by first-order flattening.  
Cluster characterization by oblique illumination microscopy (OIM). The method 
relies on light scattered at wavevectors of order Pm-1 and probe lengthscales in the range 10-3 ± 
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10 Pm.  The Rayleigh law, according to which the scattered intensity scales as the sixth power of 
WKH VFDWWHUHUV¶ VL]HV PDNHV WKLV WHFKQLTXH SDUWLFXODUO\ ZHOO VXLWHG WR VWXG\ WKH PHVRVFRSLF
clusters, which are 50- to 100 nm large, but are present at very low concentration. OIM is also 
referred to as Brownian microscopy30, 49-50 or particle tracking.51 We use Nanosight LM10-HS 
microscope (Nanosight Ltd). A green laser (532 nm) illuminates a 500 Pm solution layer at an 
oblique angle such that the incident beam avoids the lens of a microscope positioned above the 
sample, Figure 2a.50, 52 The light scattered by the clusters is seen as dark speckles in the negative 
image in Figure 2b,c; as the clusters are smaller than the diffraction limit, the speckle size 
accounts for the deviation of the cluster position from the microscope focal plane. We recorded 
the Brownian trajectory of a cluster in the image plane, Figure 2d, and computed the correlation 
between the mean squared displacement ۃȟݔଶۄ and the lag time ȟݐ, Figure 2e. We determined its 
diffusion coefficient D from the slope of the ۃȟݔଶۄሺݐሻ correlation; we used the first five data 
points as they provide the highest accuracy of D.53  
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Figure 2. Characterization of the mesoscopic OZPN-rich clusters by oblique illumination microscopy 
(OIM). (a) The OIM set up. (b) A typical image, shown as a negative, in which the clusters appear as dark 
speckles, of OZPN clusters in H2O. The observed volume is 120 × 80 × 5 Pm3 (L × W × H). (c) A typical 
image of clusters in 3 mM OZPN solution in EtOH/H2O 80/20 (v/v). (d) A typical cluster trajectory 
obtained from the position of a cluster in a sequence of images. (e) Determination of the diffusion 
coefficient D of a cluster from the correlation of its mean squared displacement ۃȟݔଶۄ and the lag time ȟݐ. First five data points are highlighted with a red line. (f) The distribution of cluster sizes obtained from 
five OIM movies recorded at distinct solution volumes.   
 
We evaluated the cluster radius R using the Stokes-Einstein relation, ܴ ൌ ݇஻ܶȀ ?ߨߟܦ
The temperature was set a T = 297.65 K and kB is the Boltzmann constant. K is the viscosity of 
the solvent, determined from the dynamics of Fluoro-Max Dyed Red fluorescent polystyrene 
spheres, with diameter 1 µm, diffusing in the tested solutions.50, 52 The viscosities of all solutions 
employed here are plotted in Figure S1. We evaluated the concentration Ncluster of clusters of 
different sizes from the number n in the monitored solution volume of V = 48,000 Pm3, Ncluster = 
n/V, Figure 2f.50, 52-53 We evaluated the volume fraction occupied by the cluster population as ߶ ൌ  ?ߨሺ ?ܴ௖ଷ݊௖ሻȀ ? ,ܸ where V is the monitored solution volume. We repeated each 
characterization of the cluster populations five times from distinct solution volumes within the 
same sample and averaged R, Ncluster, and I over the five measurements; the error bars in all plots 
represent the standard deviation of this determination. 
Determination of the optical extinction coefficient of OZPN in water-ethanol 
solvents. The ethanol concentration varied from 20 to 90 % v/v, with, correspondingly, 80 to 10 
% water. Weighted OZPN amounts were dissolved in these solvents with concentrations between 
0 and 40 PM. Completeness of dissolution was verified by the lack of scattered light using a 
device from ALV-GmbH, Langen, Germany. UV-Vis absorbance spectra were recorded, Figure 
S2. The wavelength of maximum absorbance varied between 252 nm, for 20% ethanol, to 270 
nm, for 90% ethanol. The correlations between the optical density at the wavelength of 
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maximum absorbance and the concentration were linear, Figure S2. The extinction coefficients H 
for each ethanol concentration were determined from the respective slopes and are summarized 
in Table S1.  
Determination of the temperature dependence of the OZPN solubility in water-
ethanol solvents. We added aliquots of OZPN:EtOH:H2O (2:1:2) crystals to 5 mL solution with 
one of the tested compositions held in 20 mL capped glass vials. For experimental statistics, sets 
of three vials with identical composition were stored at each of five temperatures: 4, 15, 25, 37, 
and 45°C. A 300 PL aliquot was removed after preset time from each vial, diluted with the 
respective solvent ILOWHUHG WKURXJK D  ȝP 3(6 ILOWHU DQG WKH FRQFHQWUDWLRQ RI GLVVROYHG
OZPN was determined spectrophotometrically. This procedure was repeated until the 
concentrations in each vial reached a plateau, defined by three consecutive concentrations of 
similar value, Figure S3. The final steady-state concentrations were averaged over the three 
samples for each temperature.  The resulting mean was used as the solubility Ce.  
X-ray Crystallography. XRPD patterns were obtained using a Bruker AXS D8-Advance 
transmission diffractomHWHU HTXLSSHG ZLWK șș JHRPHWU\ 7KH primary monochrome radiation 
was Cu K-D, with ZDYHOHQJWKȜ c Data were collected in the ș range íwith a 
ș VWHS RI 0.015° and 8 s/step speed. Reference powder patterns for the dihydrate ethanoate 
OZPN:EtOH:H2O (2:1:2) were computed using the Mercury 3.6 (CCDC) software from single 
crystal data from the Cambridge Structural Database.54 
RESULTS AND DISCUSSION 
Identification and reversibility of the mesoscopic OZPN-rich clusters. Undersaturated 
solutions of OZPN are expected to be homogeneous at all lengthscales, including the molecular. 
10 
 
The extinction coefficient of OZPN in water is not available in the literature, and the low 
solubility in this solvent hampered its determination. Hence, to obtain an undersaturated OZPN 
solution we started with a solution saturated with respect to OZPN DB prepared by incubating 
overnight OZPN I crystals in water under constant stirring; under these conditions, OZPN I 
transforms to OZPN DB.20 We diluted this solution with 20 % additional water by volume. The 
concentration of the diluted solution was below the solubility of OZPN DB. The most stable 
crystal form in aqueous solutions is OZPN DD; however, the transition to OZPN DD takes from 
five to seven days.20 Surprisingly, observations of the undersaturated solution with OIM revealed 
the presence of particles that randomly migrate, driven by Brownian collisions with the solvent 
molecules, Figure 2b. Careful examination of all steps in the solution preparation excluded the 
possibility that these heterogeneities are dust particles or gas bubbles.55 To test if the particles are 
crystals, we supplemented the IOM setup with a polarizer at the optical entrance of the cuvette 
and an analyzer at the optical exit, in front of the objective lens. If the polarizer and analyzer are 
in perpendicular orientation, crystals, which rotate the plane of light polarization, would produce 
bright speckles. Our tests revealed that the field of view was completely dark, disproving the 
hypothesis that the speckles seen without the polarizer in Figure 2b represent crystals. We 
conclude that these particles are disordered.  
We determined the size of the each particle from its Brownian trajectory. The average 
was ca. 35 nm. This size is similar to the clusters observed on (100) surfaces OZPN crystals in 
aqueous solutions, Figure 1. Previous AFM observations of nucleation of new crystal 
polymorphs within the clusters20 indicate that the clusters are liquid. The cluster concentration in 
the pure aqueous solvent was low, likely owing to the low OZPN concentration, constrained by 
the poor solubility. This challenged further characterization of the clusters. As ethanol (EtOH) is 
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known to significantly increase OZPN solubility,15 we prepared a solution with COZPN = 3 mM in 
80 % v/v EtOH. OIM characterization of this solution revealed a higher cluster concentration, 
Figure 2c. The size distribution, Figure 2f, is relatively narrow, between 15 and 80 nm, with a 
mean radius of ca. 35 nm.  
 
Figure 3. Evolution of the OZPN cluster population in 80 % v/v EtOH solution. (a) The average cluster 
radius R. (b) The volume fraction I in solutions with OZPN concentrations shown in (a). The averages of 
five determinations in distinct solution volumes are shown. The error bars represent the standard 
deviation. 
 
To further characterize the mesoscopic OZPN-rich clusters, we monitored the time 
evolution of the cluster population and tested the consequences of varying COZPN, Figure 3. The 
cluster radius is independent of the solution concentration and steady in time for up to three 
hours, Figure 3a. In contrast, the fraction of the solution volume occupied by the cluster 
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population I increases with COZPN and solution age, Figure 3b. We verified that the evolution of 
I is not due to OZPN precipitation or any other process in the solution hosting the clusters. The 
OZPN concentration, determined spectrophotometrically, remained steady. No changes in the 
solution UV-Vis spectra, illustrated in Figure S2, were recorded, suggesting that the I growth 
may be induced by processes occurring in the liquid comprising the clusters, which stabilize the 
clusters and increase the cluster population by spawning additional clusters of consistent size. 
The slow growth of I is consistent with slow maturation of the cluster phase. The high refractive 
index of this liquid, evidenced by the scattered intensity, suggests that the OZPN concentration 
in the clusters is higher than in the solution. The associated higher viscosity is conducive of slow 
dynamics. 
A crucial issue in understanding the cluster mechanism is whether the clusters adjust to 
the parameters of the solution, or represent irreversibly aggregated matter. As a test of cluster 
reversibility, we note that the response of I to higher COZPN is disproportional: as COZPN is raised 
by about three-fold, from 3 to 10 mM, I increases from 0.5×10-8 to 8.5×10-8, i.e., ca. 17-fold, 
Figure 3b; the latter ratio is consistent at all times, at which I is sufficiently large for accurate 
distinction between the three concentrations. The exaggerated increase of I driven by higher 
COZPN contradicts expectations for irreversible aggregates, whose concentration would increase 
proportionally to COZPN. This increase indicates that the cluster population adjusts to the solution 
conditions and the clusters do not represent irreversibly aggregated material. 
The characteristics of the cluster population revealed in Figures 2 and 3 are unusual for 
both disordered aggregates and emerging domains of a new phase, such as OZPN dense liquid. 
The narrow size distribution is inconsistent with both types of aggregation. The decoupled 
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behavior of R and I are in contrast with classical phase transitions, in which the number of 
nucleated domains and the volume that they occupy increase concurrently. The mesoscopic size 
of the clusters is steady over extended times, in sharp contrast to expectations for newly formed 
phases in which the domain size grows in time.56 This size is much larger than the prediction of 
colloid clustering models46 that are often applied to aggregation in solution.47, 57-63 As the cluster 
population captures a minor fraction of the dissolved OZPN, the concentration of the solution in 
contact with the clusters is close to the initial 3, 8, or 10 mM. This observation is beyond the 
catalogued behaviors of micelles, which equilibrate with solutions of constant critical micelle 
concentration (CMC). Thus, the OZPN clusters observed in Figures 1 ± 3 are not micelles.  
On the other hand, these characteristics are typical of the mesoscopic solute-rich clusters, 
found in solutions of numerous proteins at varying conditions.35, 48, 64-67 Similar to OZPN 
clusters, the protein cluster size is steady and independent of the parameters that define the 
solution thermodynamics, such as pH, ionic strength, and protein concentration.52, 65-66, 68 By 
contrast, the volume fraction of the clusters is determined by the solute intermolecular 
interactions.30, 48, 52, 65 A recent theory explained a range of puzzling cluster behaviors;48, 69-70 
several of the model assumptions and resulting predictions have been supported by experimental 
evidence.30, 52, 71 This model posits that the mesoscopic clusters consist of a concentrated mixture 
of intact monomers and transient dimers. The dimer lifetime determines the cluster radius R. On 
the other hand, in agreement the experimental data,30, 48, 52, 65 the cluster volume fraction I is 
dictated by the solution thermodynamics.48, 52 I is related to the solute fraction Q held in the 
clusters. Indeed, Q = ncl/nOZPN = CclVcl/COZPNV = (Ccl/COZPN)I, where ncl and nOZPN are the 
amounts of OZPN in the clusters and solution, respectively, Vcl and V are the corresponding 
volumes, and I= Vcl/V.65 The OZPN concentration in the dense liquid comprising the clusters, 
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Ccl, is significantly greater than COZPN, so that choosing a constant ratio Ccl/COZPN in the range 10 
± 100 is reasonable. Furthermore, direct application of the Boltzmann distribution suggests that Q 
| exp(±'Gcl/kBT), where 'Gcl is the free energy excess of a molecule in a clusters over that in the 
solution.48 Thus, we obtain that I is determined by the free energy balance of clusters formation 
and the decoupled behaviors of R and I emerge naturally from the model.48 
The response of the cluster population to varying EtOH concentration. To test the 
applicability of the transient dimer model to the OZPN clusters, we monitored the response of 
the cluster population to varying concentration of EtOH. The cluster radius R is independent of 
the EtOH concentration in the range 20 ± 90 %, Figure 4a. On the other hand, I depends on 
CEtOH in a complicated non-monotonic fashion, Figure 4b. Concurrently with observations of 
mesoscopic clusters in protein solutions and in compliance with the predictions of the transient 
dimer model, R and I are decoupled.    
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Figure 4. The cluster population in EtOH/H2O solvents of different composition. (a) The average cluster 
radius R. (b) The volume fraction occupied by the cluster population ĳ RQ (W2+ FRQFHQWUDWLRQ. The 
OZPN concentration was 5 mM in all experiments. The averages of five determinations in distinct 
solution volumes are shown. The error bars represent the standard deviation. 
The thermodynamics parameters of OZPN crystallization from EtOH/water 
mixtures. To understand if the variations of I in response to increasing CEtOH are driven by the 
thermodynamic parameters of the solution, we characterize the thermodynamics of OZPN 
solutions in mixed EtOH/water solvents. We choose the OZPN crystals as a reference state. X-
ray powder diffraction spectra of crystals grown at different EtOH/water ratios (Figure 5) reveal 
that OZPN crystallizes from all solvents as the OZPN dihydrate ethanoate, depicted in Scheme 
1c. The crystallization enthalpyȟܪ௖௥௬௦௧௢ , entropy ȟܵ௖௥௬௦௧௢ , and free energy ȟܩ௖௥௬௦௧௢  characterize 
the difference between the crystals and the solution. Since the crystals grown in all tested 
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solvents belong to the same polymorphic form, the disparities of ȟܪ௖௥௬௦௧௢ , ȟܵ௖௥௬௦௧௢ , and ȟܩ௖௥௬௦௧௢  in 
different solvents distinguish the state of the OZPN solute in each solvent.   
 
Figure 5. X-ray powder diffraction patterns of crystals grown in EtOH/H2O solvents with composition 
listed in the legend. Top: a model pattern computed using the software package Mercury and structure 
coordinates for the crystals of OZPN dihydrate ethanoate with Cambridge Structural Database entry 
WEXQEW.   
 
The crystallization enthalpy ȟܪ௖௥௬௦௧௢  can be measured calorimetrically by scaling the heat 
released during crystallization (at constant temperature and pressure p) with the crystallized 
mass. This determination can be distorted by solution trapped between crystals and mislabeled as 
crystalline mass. An alternative method is to determine the solubility Ce of the crystals at 
different temperatures and to employ standard thermodynamics relations and Ce(T) to 
determineȟܩ௖௥௬௦௧௢ , ȟܪ௖௥௬௦௧௢ , and ȟܵ௖௥௬௦௧௢ .72-73 
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.  
Figure 6. The solubility of OZPN with respect to the crystals of OZPN ethanol hydrate in EtOH/H2O 
solvents of composition shown the legend in (a). (a) The temperature dependence of the solubility Ce in 
the range 4 ± 45°C, dashed lines are polynomial fits. The standard deviation of three independent 
determinations carried out in parallel is smaller than the symbol size.  (d) OZPN solubility plotted in van 
¶W+RIIFRRUGLQDWHVGDVKHGOLQHVDUHOLQHDUUHJUHVVLRQILWs.  
 
The solubilities of OZPN with respect to the OZPN dihydrate ethanoate crystals in six 
CEtOH follow the expected quasi-exponential dependence on temperature, Figure 6a. The 
equilibrium constant for the reaction OZPN(solution) ' OZPN(crystals) is K = ܥ௘ି ଵ. We use that 
the product, OZPN(crystals), represents a distinct phase and its activity is assigned to be one by 
thermodynamic convention. Furthermore, owing to the low Ce, we assume that the respective 
activity coefficients are close to one. Hence, ȟܩ௖௥௬௦௧௢ ൌ  െܴ݈ܶ݊ܭ ൌ ܴ݈ܶ݊ܥ௘. To determine ȟܪ௖௥௬௦௧௢ , we use WKHYDQµW+RIIUHODWLRQZULWWHQas 
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 ൥ ߲݈݊ܥ௘߲൫ ? ܶൗ ൯൩௣ǡ௡ೕ ൌ  ?ܪ௖௥௬௦௧଴ܴ ǡ 
where nj designates the concentrations of the other solution components, EtOH and water. The 
van µW +RII UHODWLRQ VXJJHVWV WKDW WKH VORSH RI WKH FRUUelation  ܥ௘ሺܶିଵሻ is proportional to ȟܪ௖௥௬௦௧௢ . 7KHGDWDRQ2=31VROXELOLW\SORWWHGLQYDQµW+RIIFRRUGLQDWHV, Figure 6b, indicate that ȟܪ௖௥௬௦௧௢  is constant in the studied temperature range. Finally, ȟܵ௖௥௬௦௧௢ ൌ ሺȟܪ௖௥௬௦௧௢ െ ȟܩ௖௥௬௦௧௢ ሻȀܶ 
and is proportional to the intercept of the lnCe(T-1) plots, Figure 6b.  ȟܵ௖௥௬௦௧௢  is a sensitive probe of the molecular-level processes that accompany 
crystallization. An OZPN molecule in the solution is surrounded by solvent molecules, some of 
which may be associated with OZPN.74-76 For instance, water molecules exposed to the non-
polar OZPN moieties would form a structured shell, surrendering their mobility.77 Recent 
modeling suggests that five water molecules are tightly associated with each OZPN in the 
solution and are positioned in a way that preserves their bond when dimers form.20 When an 
OZPN molecule incorporates in the crystal, some of the associated solvent molecules may be 
released and in this way regain their translational and rotational degrees of freedom. ȟܵ௖௥௬௦௧௢  has 
a negative component due to the lost degrees of freedom as one OZPN, one EtOH, and two water 
molecules are confined to the crystal lattice. A positive component accounts for gained freedom 
of solvent molecules attached to OZPN in the solution and released upon crystallization. ȟܵ௖௥௬௦௧௢  
represents the balance between the two. The entropy loss corresponding to the incorporation of 
water molecules in ice is ca. ±22 J mol-1K-1, consistent for water entrapped in clathrates, crystal 
hydrates, or other ice-like structures.78-82 For the larger EtOH, the corresponding number, 
evaluated from the entropy of fusion, is ±31 J mol-1K-1.83 The relevant parameter for OZPN 
would be the entropy of crystallization from the melt, which is not available in the literature. As 
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OZPN is significantly larger than EtOH, the entropy lost upon entrapment should have greater 
magnitude than ±31 J mol-1K-1.  
 
Figure 7. The thermodynamic parameters of crystallization of OZPN ethanol hydrate in EtOH/H2O 
solvents of different. (a) The crystallization entropy ȟܵ௖௥௬௦௧௢ . (b) The crystallization enthalpy ȟܪ௖௥௬௦௧௢ . (c) 
The Gibbs free energy ȟܩ௖௥௬௦௧௢  at 298 K. The error bars in (a) and (b) represent the standard deviation of 
the intercept and slope, respectively, of the linear correlations in Figure 6b. The standard deviation for 
ǻG° was determined form that of Ce and is smaller than the symbol size.  
 
The dependence of ȟܵ௖௥௬௦௧௢  on the EtOH content in the solvent transitions sharply from ±
3 to ±62 J mol-1K-1 as the CEtOH increases from 20 to 30 % v/v and stays constant for CEtOH 
between 30 and 90 % v/v, Figure 7a. The values of ȟܵ௖௥௬௦௧௢  at both sides of the transition result 
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from the balance of confined OZPN, EtOH, and water and released solvent molecules and cannot 
be interpreted in the absence of data on the structure of the solute ± solvent complexes. The 
magnitude of the transition, however, ca. 60 J mol-1K-1, suggests that three water molecules may 
be associated with OZPN in the 20 % EtOH solution and set free upon incorporation of OZPN 
into the crystal. This number is consistent with the five waters predicted to tightly bind to 
OZPN20 and the two water molecules trapped in the lattice. In solutions with EtOH content of 30 
% v/v and higher, these water molecules are displaced from the vicinity of OZPN and do not 
affect the entropy balance of crystallization. The constant value of ȟܵ௖௥௬௦௧௢  in the EtOH range 
from 30 to 90 % v/v suggest that no additional water molecules are dissociated from solute 
OZPN by higher EtOH concentrations.   
 
Scheme 2. The enthalpies of the solution and crystal emerging from the ȟܪ௖௥௬௦௧௢  data in Figure 7b. The 
arrows indicate the transition from solution to crystals and their negative direction corresponds to the sign 
of ȟܪ௖௥௬௦௧௢ . ܪ௦௢௟௨௧௜௢௡ varies with the EtOH content antisymmetrically to ȟܪ௖௥௬௦௧௢ .  
 ȟܪ௖௥௬௦௧௢  denotes the difference of the enthalpies of OZPN in the crystal and solution, ȟܪ௖௥௬௦௧௢ ൌ ܪ௖௥௬௦௧௔௟ െ ܪ௦௢௟௨௧௜௢௡. Since the crystals forming at different CEtOH are identical, ܪ௖௥௬௦௧௔௟ does not depend on the EtOH content and the variations of ȟܪ௖௥௬௦௧௢  are determined by ܪ௦௢௟௨௧௜௢௡, Scheme 2. ܪ௦௢௟௨௧௜௢௡ is a measure of solution non-ideality due to intermolecular 
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attraction and repulsion, with higher ܪ௦௢௟௨௧௜௢௡ implying stronger repulsion.84 Thus, the low 
magnitude of ȟܪ௖௥௬௦௧௢  at 20 % EtOH, Figure 7b, suggests small ܪ௦௢௟௨௧௜௢௡, corresponding to mild 
repulsion between the OZPN molecules in the solution. The likely moderating force is the 
hydrophobic attraction induced by the structured water, indicated by the ȟܵ௖௥௬௦௧௢  datum for this 
solvent in Figure 7a. As the structured water molecules are stripped at CEtOH equal or greater than 
30 %, ܪ௦௢௟௨௧௜௢௡, Scheme 2, suggests stronger intermolecular repulsion that may be due to the 
hydration shells of the polar nitrogen groups of OZPN, Scheme 1a; note that in contrast to non-
polar moieties, water structured at polar groups induces repulsion due to its strong association 
with the solute.74, 85 The attenuated repulsion at higher CEtOH may be due to the lower dielectric 
constant of these solutions, conducive of stronger van der Waals attraction.86 ȟܩ௖௥௬௦௧௢  is a 
convolution of ȟܪ௖௥௬௦௧௢  and ȟܵ௖௥௬௦௧௢ .  
Solution thermodynamics dictates the cluster volume fraction. To understand the 
non-monotonic dependence of I on the EtOH content, Figure 4b, we note that direct application 
of the relation between I and 'Gcl, derived above, is not feasible since data on 'Gcl are 
unavailable. We use the suggestions for ܪ௦௢௟௨௧௜௢௡ in solvents of different composition, Scheme 2, 
as an indicator for the intermolecular interactions between the solute molecules. The variations 
of ܪ௦௢௟௨௧௜௢௡ parallel those of I. This synchronous behavior suggests that stronger repulsion 
between the solute OZPN molecules, indicated by higher ܪ௦௢௟௨௧௜௢௡, drives the fraction Q and the 
correlated volume I. In agreement with the transient dimer model of cluster formation, the 
cluster population volume and the fraction of solute captures in the clusters are determined by 
the solution thermodynamics.  
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The dimer identity is the final step in the application of the transient dimer model to the 
OZPN-rich clusters. The known experimental crystal structures of neutral OZPN are comprised 
of the so-called SC0 dimer, a centrosymmetric motif depicted in Scheme 1b.15 14, 17 We put forth 
that the transient dimer may be akin to that structure. Future work to test this hypothesis is under 
way.  
The finding of the thermodynamic control of the cluster phase volume and the suggested 
dimer identity imply a thermodynamic and a structural pathways to control the cluster population 
and hence the nucleation and polymorph transformation pathways directed by the clusters, as 
seen by Warzecha et al.20 The thermodynamic parameters of the solution may be modified by 
low-concentration additives that act on the intermolecular interactions. The dimer may be 
suppressed by a subtle structural modification of the molecule, compatible with its biological 
activity.  
Conclusions 
We demonstrate that solutions of the antipsychotic drug OZPN in purely aqueous and 
mixed EtOH/aqueous solvents exhibit solute-rich clusters of radius R ca. 35 nm that occupy 
about 10-8 ± 10-7 of the solution volume and capture ca. 10-7 ± 10-5 of the OZPN in the solution. 
The clusters are disordered and likely liquid and do not represent any of the known OZPN 
condensed phases. The clusters are of interest since previous work suggests that they may be 
crucial sites for the nucleation of emerging crystal forms in the course of OZPN polymorph 
transitions.  
We find that the cluster radius R is steady in time and independent of the OZPN 
concentration and the solvent composition. On the other hand, the volume of the cluster 
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population I, related to the fraction of OZPN molecules captured in the clusters Q, is a sensitive 
function of both parameters. We demonstrate that I and Q are dictated by the thermodynamics of 
the OZPN solution. The steady mesoscopic R, decoupled from the volume of the clusters phase, 
contradicts predictions of classical theories of phase transformation and recent aggregation 
models. These discrepancies suggests that the OZPN-rich clusters represent a unique condensed 
phase. We demonstrate that the unusual cluster behaviors are consistent with the predictions of a 
model that assumes the formation of OZPN dimers and their decay upon exiting the clusters. We 
propose that a transient dimer, akin to the centrosymmetric motif present in most of the 60 
known OZPN crystal structures, may be the oligomer underlying cluster formation. 
Our findings suggest that the cluster population and the nucleation and polymorph 
transformation pathways, mediated by the clusters, can be controlled by modifying the 
thermodynamic parameters of the solution and suppressing the formation of dimers or other 
oligomers. 
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